Primer probe combination and kit for identifying and detecting African swine fever typing, wild virus and deletion virus

By providing specific primer probe combinations and multiple TaqMan fluorescence quantitative PCR kits, the problems of genotyping and virulence identification in ASFV detection are solved, and the rapid and accurate identification of ASFV is achieved, and the detection efficiency and accuracy are improved. Suitable for different laboratory conditions.

CN118996007APending Publication Date: 2024-11-22XIAJIN NEW HOPE LIUHE AGRICULTURE & ANIMAL HUSBANDRY CO LTD +5
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411241996.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-05
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing ASFV detection methods cannot simultaneously quickly and accurately realize genotyping and virulence identification, and the detection sensitivity is reduced due to the mutual interference between detection sites, so it is impossible to effectively distinguish African swine fever type I and II viruses and identify them. Gene deletion strains and wild-type strains.

Method used

Provide a primer probe combination and multiple TaqMan fluorescence quantitative PCR kit for African swine fever typing, wild poison and deletion poison identification. Through specific primer and probe combinations and fluorescent labeling, it can quickly distinguish in a reaction. Different genotypes and virulence of ASFV avoid cross-interference between sites.

Benefits of technology

It realizes rapid and accurate identification of ASFV, improves detection efficiency and accuracy, has high sensitivity, can detect trace viral DNA, avoid missed detection, and has good repetition and applicability, suitable for laboratory and clinical diagnosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118996007A_ABST
    Figure CN118996007A_ABST
Patent Text Reader

Abstract

The invention provides a primer probe combination and a kit for identifying and detecting African swine fever typing, wild virus and deletion virus, and belongs to the technical field of virus detection. The primer probe combination comprises a specific primer and probe combination aiming at ASFV I-type attenuated virus, I-type virulent virus, II-type attenuated virus, II-type wild virus and I177L gene deleted vaccine virus, and multiple detection is carried out by utilizing probes labeled by different fluorescently. The kit can quickly and accurately distinguish the various virus types in one PCR reaction, and has high specificity and high sensitivity, and the lowest detection limit can reach 2.29 copies / [mu] L or 4.15 copies / [mu] L. Meanwhile, experimental results show that the method has good repeatability and reliability and is suitable for ASFV diagnosis detection and epidemiological investigation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of virus detection, and in particular relates to a primer-probe combination and a kit for typing, identifying and detecting wild-type and deletion viruses of African swine fever. Background Art

[0002] African swine fever (ASF) is an acute, severe and highly contagious viral infectious disease caused by infection with African swine fever virus (ASFV). The natural hosts of ASFV are domestic pigs, wild boars and Ornithodoros ticks, and it can be transmitted mainly through the digestive tract, respiratory tract and insect vectors. It has strong resistance to the environment, a wide range of incubation periods in pigs, strong transmission and high mortality rate. ASF was discovered in Kenya in 1921 and has since broken out and spread in nearly 50 countries in Africa, Asia, Europe and the Caribbean, seriously endangering the stable development of the global pig industry and related industries, and causing huge economic losses to society. In 2018, ASF was introduced into China for the first time, and the genotype II virulent strain (ASFV HLJ / 18) was isolated for the first time, with a mortality rate of 100% for inoculated pigs. Subsequently, a genotype II weak strain (HLJ / HRB1 / 20) appeared in 2020, a genotype I weak strain (SD / DY-I / 21) appeared in 2021, and a type I strong strain (JS / LG / 21) that was naturally recombined between genotypes I and II appeared in 2023. This recombinant strain is highly lethal and contagious to domestic pigs, posing even more severe challenges to China's ASF prevention and control.

[0003] At present, there is no ASF vaccine approved for use, so effective monitoring through pathogen detection and timely elimination of the source of infection remain the main measures for ASF prevention and control. The p72 protein of ASFV is highly conservative and has good immunogenicity. It is not only a structural protein for diagnosis, but also an important target gene for fluorescence quantitative detection and typing. With the changes in the ASF epidemic situation and the emergence of ASFV variants, genes such as CD2v, MGF, and I177L have been studied in natural attenuated strains and constructed gene-deficient strains.

[0004] However, most of the ASFV identification methods reported so far are ASFV genotype I and II typing tests, or the identification of gene-deficient strains and wild-type strains. These tests cannot simultaneously and quickly and accurately meet the requirements of genotyping and viral virulence identification. Although these detection methods perform well in specific application scenarios, they cannot simultaneously and quickly and accurately achieve genotyping and viral virulence identification. When primers and probes of different viruses are simply combined, the complexity of the detection system increases due to the need to simultaneously detect multiple gene sites, causing mutual interference between different detection sites. This mutual interference reduces the overall detection sensitivity and leads to problems of missed detection and false detection. Therefore, it is currently necessary to establish a rapid, low-cost, highly sensitive, easy-to-use detection primer probe combination, kit and method for the ASFV gene that can specifically distinguish between genotype I and type II viruses and can identify gene-deficient strains and wild-type strains. Summary of the invention

[0005] The purpose of the present invention is to provide a primer-probe combination and a kit for African swine fever typing, wild virus and deletion virus identification and detection, so as to meet the needs of veterinary detection or researchers at different levels.

[0006] To achieve the above object, the present invention provides the following technical solutions:

[0007] First, the present invention provides a primer-probe combination for identifying and detecting African swine fever typing virus, wild virus and deletion virus, wherein the African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deletion virus is I177L gene deletion vaccine virus;

[0008] The primer-probe combination includes a first primer and a first probe combination, a second primer and a second probe combination, a third primer and a third probe combination, a fourth primer and a fourth probe combination, and a fifth primer and a fifth probe combination;

[0009] The forward primer sequence of the first primer is shown in SEQ ID NO.1;

[0010] The reverse primer sequence of the first primer is shown in SEQ ID NO.2;

[0011] The sequence of the first probe is shown in SEQ ID NO.3;

[0012] The forward primer sequence of the second primer is shown in SEQ ID NO.4;

[0013] The reverse primer sequence of the second primer is shown in SEQ ID NO.5;

[0014] The sequence of the second probe is shown in SEQ ID NO.6;

[0015] The forward primer sequence of the third primer is shown in SEQ ID NO.7;

[0016] The reverse primer sequence of the third primer is shown in SEQ ID NO.8;

[0017] The sequence of the third probe is shown in SEQ ID NO.9;

[0018] The forward primer sequence of the fourth primer is shown in SEQ ID NO.10;

[0019] The reverse primer sequence of the fourth primer is shown in SEQ ID NO.11;

[0020] The sequence of the fourth probe is shown in SEQ ID NO.12;

[0021] The forward primer sequence of the fifth primer is shown in SEQ ID NO.13;

[0022] The reverse primer sequence of the fifth primer is shown in SEQ ID NO.14;

[0023] The sequence of the fifth probe is shown as SEQ ID NO.15.

[0024] Preferably, the 5' end of the first probe is labeled with a FAM fluorescent group, and the 3' end is labeled with a BHQ1 group;

[0025] The 5' end of the second probe is labeled with a VIC fluorescent group, and the 3' end is labeled with a BHQ1 group;

[0026] The 5' end of the third probe is labeled with a ROX fluorescent group, and the 3' end is labeled with a BHQ2 group;

[0027] The 5' end of the fourth probe is labeled with a CY5 fluorescent group, and the 3' end is labeled with an MGB group;

[0028] The 5' end of the fifth probe is labeled with a CY5.5 fluorescent group, and the 3' end is labeled with a BHQ2 group.

[0029] Preferably, the target gene sequence of the first primer is shown as SEQ ID NO.16;

[0030] The target gene sequence of the second primer is shown in SEQ ID NO.17;

[0031] The target gene sequence of the third primer is shown in SEQ ID NO.18;

[0032] The target gene sequence of the fourth primer is shown in SEQ ID NO.19;

[0033] The target gene sequence of the fifth primer is shown as SEQ ID NO.20.

[0034] Secondly, the present invention provides a multiplex TaqMan fluorescent quantitative PCR kit for identification and detection of African swine fever typing virus, wild virus and deletion virus, which is characterized in that the kit comprises the primer-probe combination as claimed in claim 1;

[0035] The African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deleted virus is the I177L gene deleted vaccine virus.

[0036] Preferably, each 20uL PCR amplification system of the kit is:

[0037] 10uL 2×AceQ Universal U + Probe Master Mix V2, 2.5uL primer probe combination, 3.5uL ddH2O, 4uL total sample DNA;

[0038] The volume ratio of the primer and the probe in the primer-probe combination is: forward primer: reverse primer: probe = 2:2:1.

[0039] Preferably, the reaction conditions of the kit for fluorescent quantitative PCR reaction are:

[0040] 37℃ for 2 min; 95℃ for 5 min; 95℃ for 10 s, 60℃ for 30 s, 40 cycles, and the fluorescence values ​​of five channels, FAM, VIC, ROX, Cy5, and CY5.5, were collected simultaneously.

[0041] Preferably, the judgment criteria after the kit detection are as follows:

[0042] When the Ct value of the FAM channel is less than 40 and there is an obvious amplification curve, the VIC channel has no Ct value, the ROX channel has no Ct value, the CY5 channel has no Ct value, and the CY5.5 channel has a Ct value less than 40 and there is an obvious amplification curve, the result is determined to be African swine fever type I attenuated virus;

[0043] When the Ct value of the FAM channel is <40 and there is an obvious amplification curve, the VIC channel has no Ct value, the ROX channel Ct is <40 and there is an obvious amplification curve, the CY5 channel Ct is <40 and there is an obvious amplification curve, and the CY5.5 channel Ct is <40 and there is an obvious amplification curve, the result is determined to be African swine fever type I strong virus;

[0044] When there is no Ct value in the FAM channel, the Ct value of the VIC channel is <40 and there is an obvious amplification curve, only one of the ROX channel and the CY5 channel has an amplification curve or both have no amplification curve, and the Ct value of the CY5.5 channel is <40 and there is an obvious amplification curve, the result is determined to be African swine fever type II attenuated virus;

[0045] When there is no Ct value in the FAM channel, the Ct value of the VIC channel is less than 40 and there is an obvious amplification curve, the Ct value of the ROX channel is less than 40 and there is an obvious amplification curve, the Ct value of the CY5 channel is less than 40 and there is an obvious amplification curve, and the Ct value of the CY5.5 channel is less than 40 and there is an obvious amplification curve, the result is determined to be African swine fever type II wild virus;

[0046] When there is no Ct value in the FAM channel, the Ct of the VIC channel is less than 40 and there is an obvious amplification curve, the Ct of the ROX channel is less than 40 and there is an obvious amplification curve, the Ct of the CY5 channel is less than 40 and there is an obvious amplification curve, and there is no Ct value in the CY5.5 channel, the result is determined to be the I177L gene deletion vaccine virus;

[0047] When there is no Ct value in the FAM channel, no Ct value in the VIC channel, no Ct value in the ROX channel, no Ct value in the CY5 channel, and no Ct value in the CY5.5 channel, the result is judged to be negative.

[0048] Secondly, the present invention provides a method for identifying and detecting African swine fever typing virus, wild virus and deletion virus for non-diagnostic purposes, characterized in that the African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deletion virus is I177L gene deletion vaccine virus;

[0049] The method comprises the following steps:

[0050] (1) Obtaining total DNA of the test sample;

[0051] (2) preparing reagents according to the above-mentioned PCR amplification system;

[0052] (3) performing PCR amplification according to the above reaction conditions;

[0053] (4) Determine the results according to the above criteria.

[0054] Secondly, the present invention provides the use of a primer-probe combination in the preparation of biological preparations for the identification and detection of African swine fever typing viruses, wild viruses and deletion viruses. The African swine fever typing viruses are African swine fever type I attenuated viruses, African swine fever type I strong viruses, and African swine fever type II attenuated viruses. The wild viruses are African swine fever type II wild viruses, and the deletion viruses are I177L gene deletion vaccine viruses.

[0055] In addition, the present invention provides the use of a kit in the preparation of an identification and detection system for African swine fever typing viruses, wild viruses and deletion viruses, wherein the African swine fever typing viruses are African swine fever type I attenuated viruses, African swine fever type I strong viruses, and African swine fever type II attenuated viruses, the wild viruses are African swine fever type II wild viruses, and the deletion viruses are I177L gene deletion vaccine viruses.

[0056] The beneficial effects of the present invention are:

[0057] 1. The primer probe combination and kit provided by the present invention can simultaneously detect African swine fever type I attenuated virus, type I virulent virus, type II attenuated virus, type II wild virus and I177L gene-deficient vaccine virus, meeting the demand for accurate identification of different genotypes and virulence. Through multiplex TaqMan fluorescence quantitative PCR technology, these virus types can be quickly distinguished in one reaction, effectively improving the detection efficiency and accuracy.

[0058] 2. Using probes with different fluorescent labels ensures the specific detection of each gene site and avoids cross-interference between different sites. The method of the present invention has extremely high sensitivity, with a minimum detection limit of 2.29 copies / μL or 4.15 copies / μL, ensuring that trace amounts of viral DNA can be detected and avoiding missed detection.

[0059] 3. Through multiple experimental verifications, the detection method of the present invention has a low coefficient of variation within and between groups (0.04%-0.89%), showing good repeatability, thus ensuring the reliability of the detection results.

[0060] 4. The primer-probe combination and kit of the present invention are suitable for identifying different genotypes of African swine fever virus. They can be used not only in laboratory research, but also in clinical diagnosis and epidemiological investigations, providing a powerful tool for the prevention and control of African swine fever.

[0061] 5. The detection system provided by the present invention is simple and easy in the PCR operation process, does not require complicated operation steps or equipment, is suitable for promotion and application under various laboratory conditions, and has wide application potential.

[0062] These advantages make the present invention have important practical application value in the accurate detection and identification of African swine fever virus, and can effectively support the formulation and implementation of disease prevention and control measures. BRIEF DESCRIPTION OF THE DRAWINGS

[0063] Figure 1 is the standard curve corresponding to the primer probe targeting type I gene;

[0064] Figure 2 is the standard curve corresponding to the primer probe targeting type II gene;

[0065] Figure 3 is the standard curve corresponding to the primer probe for the MGF gene;

[0066] Figure 4 is the standard curve corresponding to the primer probe for CD2V gene;

[0067] Figure 5 is the standard curve corresponding to the primer probe for the I177L gene;

[0068] Figure 6 It is the specific detection result of multiplex TaqMan fluorescence quantitative PCR;

[0069] In the figure, the curves from top to bottom represent MGF, type I, type II, CD2V, I177L, PRRSV, PEDV, CSFV, PRV, TGEV, PCV2, PCV3, and NC;

[0070] Figure 7 This is the sensitivity test result of multiplex TaqMan fluorescence quantitative PCR for type I gene;

[0071] In the figure, the curves from left to right are 2.29×10 9 , 2.29×10 8 , 2.29×10 7 , 2.29×10 6 , 2.29×10 5 , 2.29×10 4 , 2.29×10 3 , 2.29×10 2 , 2.29×10 1 , 2.29×10 0 Detection curve of copies;

[0072] Figure 8 This is the sensitivity test result of multiplex TaqMan fluorescence quantitative PCR for type II gene;

[0073] In the figure, the curves from left to right are 2.29×10 9 , 2.29×10 8 , 2.29×10 7 , 2.29×10 6 , 2.29×10 5 , 2.29×10 4 , 2.29×10 3 , 2.29×10 2 , 2.29×10 1 , 2.29×10 0 Detection curve of copies;

[0074] Fig. 9 The results of the sensitivity test of MGF gene by multiplex TaqMan fluorescence quantitative MGF;

[0075] In the figure, the curves from left to right are 4.15×10 10 , 4.15×10 9 , 4.15×10 8 , 4.15×10 7 , 4.15×10 6 , 4.15×10 5 , 4.15×10 4 , 4.15×10 3 , 4.15×10 2 , 4.15×10 1 , 4.15×10 0 Detection curve of copies;

[0076] Fig.10 The results of multiplex TaqMan fluorescence quantitative CD2V sensitivity test for MGF gene;

[0077] In the figure, the curves from left to right are 4.15×10 10 , 4.15×10 9 , 4.15×10 8 , 4.15×10 7 , 4.15×10 6 , 4.15×10 5 , 4.15×10 4 , 4.15×10 3 , 4.15×10 2 , 4.15×10 1 , 4.15×10 0 Detection curve of copies;

[0078] Fig.11 This is the result of multiplex TaqMan fluorescence quantitative I177L sensitivity test for MGF gene;

[0079] In the figure, the curves from left to right are 4.15×10 10 , 4.15×10 9 , 4.15×10 8 , 4.15×10 7 , 4.15×10 6 , 4.15×10 5 , 4.15×10 4 , 4.15×10 3 , 4.15×10 2 , 4.15×101 , 4.15×10 0 Detection curve of copies. DETAILED DESCRIPTION

[0080] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.

[0081] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0082] Example 1

[0083] Primer and probe design

[0084] Primers and probes were designed based on the sequences of P72 gene, MGF gene, CD2V gene and I177L gene in GenBank:

[0085] Among them, the type I probe is labeled with a FAM fluorescent group at its 5' end and a BHQ1 group at its 3' end, the type II probe is labeled with a VIC fluorescent group at its 5' end and a BHQ1 group at its 3' end, the MGF probe is labeled with a ROX fluorescent group at its 5' end and a BHQ2 group at its 3' end, the CD2V probe is labeled with a CY5 fluorescent group at its 5' end and a MGB group at its 3' end, and the I177L probe is labeled with a CY5.5 fluorescent group at its 5' end and a BHQ2 group at its 3' end. The primers and probes are shown in Table 1 below.

[0086] Table 1 Multiplex PCR primer and probe combinations for African swine fever virus detection

[0087]

[0088]

[0089] Note: In the table, F is the forward primer, R is the reverse primer, and P is the probe sequence.

[0090] Example 2

[0091] Preparation of recombinant plasmid standards

[0092] Ⅰ The target gene sequence is as follows:

[0093] gatgaacatgcgtctggaagagctgtatctctatcctgaaagctttatctctgcgtggtgagtaggctgcataatggc gttaacaacatgtccgaacttgtgccaatc, SEQ ID NO.1 6;

[0094] Ⅱ The target gene sequence is as follows:

[0095] gatgaacatgcgtctggaagagctgtatctctatcctgaaagctttatctctgcgtggtgagtgggctgcataatggc gttaacaacatgtccgaacttgtgccaatc, SEQ ID NO.1 7;

[0096] The MGF target gene sequence is as follows:

[0097] tccttttcatacgcctcatgaaggtcaaacacattattaaaacaaagagcacatgttaaccgccacgtattcaggtgt gtatatttttggtaaaaatactgtatggcctctttcag, SEQ ID NO.1 8;

[0098] The CD2V target gene sequence is as follows:

[0099] aagaaatagaaagtccaccacctgaatctaatgaagaagaacaatgtcagcatgatgacaccacttccatacatg aaccatctcccagagaaccattacttcctaagcct, SEQ ID NO.1 9;

[0100] The I177L target gene sequence is as follows:

[0101] aactggaaaaaactttaacggcataattatcaaatgcgaagggggatccgtataaaatcctagcttgccggtaatg gctattaagttaaatttggt, SEQ ID NO. 20;

[0102] Standard plasmids pUC57-I, pUC57-II, pUC57-MGF, pUC57-CD2V, and pUC57-I177L were synthesized by Sangon Biotechnology (Shanghai) Co., Ltd. and stored in the laboratory. The concentration of standard plasmids was measured using NanoDrop 2000C (ThermoFisher Scientific).

[0103] The gene copy number calculation formula is as follows: Y (copies / μL) = [plasmid DNA concentration (ng / μL) × 10 -9 / (plasmid DNA length bp×660)]×6.02×10 23 The gene copy numbers of the standard plasmids were determined to be 2.29×10 10 copies / μL(pUC57-Ⅰ, pUC57-Ⅱ), 4.15×10 10 copies / μL(pUC57-MGF), 4.15×10 10 copies / μL(pUC57-CD2V), 4.15×10 10 copies / μL(pUC57-I177L).

[0104] Example 3

[0105] Reaction system and reaction conditions for multiplex TaqMan fluorescence quantitative PCR detection

[0106] The 20 μL reaction system for multiplex TaqMan fluorescence quantitative PCR detection is as follows:

[0107]

[0108]

[0109] Reaction conditions for multiplex TaqMan fluorescence quantitative PCR assay:

[0110] 37℃ for 2 min; 95℃ for 5 min; 95℃ for 10 s, 60℃ for 30 s, 40 cycles, and the fluorescence values ​​of five channels, FAM, VIC, ROX, Cy5, and CY5.5, were collected simultaneously.

[0111] Example 4

[0112] Judgment criteria for multiplex TaqMan fluorescence quantitative PCR detection

[0113] The judgment criteria for multiplex TaqMan fluorescence quantitative PCR detection are shown in Table 2 below:

[0114]

[0115]

[0116] Example 5

[0117] Construction of reaction standard curve for multiplex TaqMan fluorescence quantitative PCR detection

[0118] The standard obtained in Example 2 was diluted 10 times in a gradient manner to obtain the following concentration range:

[0119] 2.29×10 9 -2.29×10 0 copies / uL of type I positive plasmid, 2.29×10 9 -2.29×10 0 copies / uL of type II positive plasmid, 4.15×10 10 -4.15×10 0 copies / μL of MGF positive plasmid, 4.15×10 10 -4.15×10 0 copies / μ of CD2V positive plasmid, 4.15×10 10 -4.15×10 0 copies / μ of I177L positive plasmid.

[0120] According to the primers and probes in Example 1, the reaction system and reaction conditions given in Example 3, fluorescence quantitative PCR detection was performed to establish a standard curve.

[0121] The standard curve corresponding to the primer probe for type I is Y=-3.185x+37.613, R2=0.997, and the amplification efficiency is 106.0% ( Figure 1 ); The standard curve corresponding to the primer probe for type II is Y = -3.398x + 40.159, R2 = 0.999, and the amplification efficiency is 96.9% ( Figure 2 ); The standard curve corresponding to the primer probe for MGF is Y = -3.490x + 36.333, R2 = 0.999, and the amplification efficiency is 93.4% ( Figure 3 ); The standard curve corresponding to the primer probe for CD2V is Y=-3.469x+37.744, R2=1.000, and the amplification efficiency is 94.2% ( Figure 4 ); The standard curve corresponding to the primer probe for I177L is Y = -3.510x + 36.122, R2 = 0.998, and the amplification efficiency is 92.7% ( Figure 5 ).

[0122] Example 6

[0123] Specific detection of multiplex TaqMan fluorescence quantitative PCR

[0124] According to the primers and probes in Example 1, the reaction system and reaction conditions given in Example 3 were used to detect porcine reproductive and respiratory syndrome virus (PRRSV), porcine epidemic diarrhea (PEDV), classical swine fever virus (CSFV), pseudorabies virus (PRV), porcine transmissible gastroenteritis virus (TGEV), porcine circovirus type 2 (PCV2), and porcine circovirus type 3 (PCV3);

[0125] At the same time, positive controls were set up using pUC57-Ⅰ, pUC57-Ⅱ, pUC57-MGF, pUC57-CD2V, and pUC57-I177L standard plasmids as templates, and negative controls were set up using sterile nuclease-free water as template.

[0126] The experimental results are as follows Figure 6 As shown: it can be seen that only the positive control has a specific amplification curve, and the other common porcine viruses and the negative control do not show amplification. Therefore, the multiplex TaqMan fluorescent quantitative PCR detection method established in the present invention has good specificity.

[0127] Example 7

[0128] Multiplex TaqMan fluorescence quantitative PCR sensitivity test

[0129] The recombinant plasmid standard in Example 2 was diluted 10 times in a row, and each dilution group was used as a template for the multiplex fluorescence quantitative PCR detection method. The detection was performed according to the primers and probes in Example 1 and the reaction system and reaction conditions given in Example 3.

[0130] The detected results are as follows Figure 7-11 As shown. Among them, pUC57-Ⅰ is 2.29×10 9 -2.29×10 0 copies / uL have amplification curves ( Figure 7 ), pUC57-Ⅱ at 2.29×10 9 -2.29×10 0 copies / uL have amplification curves ( Figure 8 ), pUC57-MGF at 4.15×10 10 -4.15×10 0 There are amplification curves ( Fig. 9 ), pUC57-CD2V at 4.15×10 10 -4.15×10 0 There are amplification curves ( Fig.10 ), pUC57-I177L at 4.15×1010 -4.15×10 0 There are amplification curves ( Fig.11 ), indicating that the minimum template copy number that can be detected for type I and type II genes is 2.29 copies, and the minimum template copy number that can be detected for MGF, CD2V and I177L genes is 4.15 copies, which has extremely excellent sensitivity.

[0131] Example 8

[0132] Multiplex TaqMan fluorescence quantitative PCR sensitivity test

[0133] Five serial dilutions of standard plasmids were selected for the five detection genes, and three batches of repeated fluorescence quantitative PCR detection were performed according to the primers and probes in Example 1, the reaction system and reaction conditions given in Example 3. Three replicates were set for each dilution in each batch, and the obtained Ct values ​​were statistically analyzed to calculate the intra-group and inter-group coefficients of variation. The results are shown in Table 3.

[0134]

[0135] The results in Table 3 show that the method has good intra-group and inter-group repeatability, with intra-group variation coefficients ranging from 0.04% to 0.89% and inter-group variation coefficients ranging from 0.04% to 0.88%.

Claims

1. A primer-probe combination for identifying and detecting African swine fever virus, wild virus and deletion virus, characterized in that: The African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deleted virus is I177L gene deleted vaccine virus; The primer-probe combination includes a first primer and a first probe combination, a second primer and a second probe combination, a third primer and a third probe combination, a fourth primer and a fourth probe combination, and a fifth primer and a fifth probe combination; The forward primer sequence of the first primer is shown in SEQ ID NO.1; The reverse primer sequence of the first primer is shown in SEQ ID NO.2; The sequence of the first probe is shown in SEQ ID NO.3; The forward primer sequence of the second primer is shown in SEQ ID NO.4; The reverse primer sequence of the second primer is shown in SEQ ID NO.5; The sequence of the second probe is shown in SEQ ID NO.6; The forward primer sequence of the third primer is shown in SEQ ID NO.7; The reverse primer sequence of the third primer is shown in SEQ ID NO.8; The sequence of the third probe is shown in SEQ ID NO.9; The forward primer sequence of the fourth primer is shown in SEQ ID NO.10; The reverse primer sequence of the fourth primer is shown in SEQ ID NO.11; The sequence of the fourth probe is shown in SEQ ID NO.12; The forward primer sequence of the fifth primer is shown in SEQ ID NO.13; The reverse primer sequence of the fifth primer is shown in SEQ ID NO.14; The sequence of the fifth probe is shown as SEQ ID NO.

15.

2. The primer-probe combination according to claim 1, characterized in that: The 5' end of the first probe is labeled with a FAM fluorescent group, and the 3' end is labeled with a BHQ1 group; The 5' end of the second probe is labeled with a VIC fluorescent group, and the 3' end is labeled with a BHQ1 group; The 5' end of the third probe is labeled with a ROX fluorescent group, and the 3' end is labeled with a BHQ2 group; The 5' end of the fourth probe is labeled with a CY5 fluorescent group, and the 3' end is labeled with an MGB group; The 5' end of the fifth probe is labeled with a CY5.5 fluorescent group, and the 3' end is labeled with a BHQ2 group.

3. The primer-probe combination according to claim 2, characterized in that: The target gene sequence of the first primer is shown in SEQ ID NO.16; The target gene sequence of the second primer is shown in SEQ ID NO.17; The target gene sequence of the third primer is shown in SEQ ID NO.18; The target gene sequence of the fourth primer is shown in SEQ ID NO.19; The target gene sequence of the fifth primer is shown as SEQ ID NO.

20.

4. A multiplex TaqMan fluorescent quantitative PCR kit for the identification and detection of African swine fever virus, wild virus and deletion virus, which is characterized in that: The kit comprises the primer-probe combination as claimed in claim 1; The African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deleted virus is the I177L gene deleted vaccine virus.

5. The multiplex TaqMan fluorescent quantitative PCR kit according to claim 4, characterized in that: Each 20uL PCR amplification system of the kit is: 10uL 2×AceQ Universal U + Probe Master Mix V2, 2.5uL primer probe combination, 3.5uL ddH2O, 4uL total sample DNA; The volume ratio of the primer and the probe in the primer-probe combination is: forward primer: reverse primer: probe = 2:2:

1.

6. The multiplex TaqMan fluorescent quantitative PCR kit according to claim 5, characterized in that: The reaction conditions of the kit for fluorescent quantitative PCR reaction are: 37℃ for 2 min; 95℃ for 5 min; 95℃ for 10 s, 60℃ for 30 s, 40 cycles, and the fluorescence values ​​of five channels, FAM, VIC, ROX, Cy5, and CY5.5, were collected simultaneously.

7. The multiplex TaqMan fluorescent quantitative PCR kit according to claim 6, wherein the criteria after detection by the kit are as follows: When the Ct value of the FAM channel is less than 40 and there is an obvious amplification curve, the VIC channel has no Ct value, the ROX channel has no Ct value, the CY5 channel has no Ct value, and the CY5.5 channel has a Ct value less than 40 and there is an obvious amplification curve, the result is determined to be African swine fever type I attenuated virus; When the Ct value of the FAM channel is <40 and there is an obvious amplification curve, the VIC channel has no Ct value, the ROX channel Ct is <40 and there is an obvious amplification curve, the CY5 channel Ct is <40 and there is an obvious amplification curve, and the CY5.5 channel Ct is <40 and there is an obvious amplification curve, the result is determined to be African swine fever type I strong virus; When there is no Ct value in the FAM channel, the Ct value of the VIC channel is <40 and there is an obvious amplification curve, only one of the ROX channel and the CY5 channel has an amplification curve or both have no amplification curve, and the Ct value of the CY5.5 channel is <40 and there is an obvious amplification curve, the result is determined to be African swine fever type II attenuated virus; When there is no Ct value in the FAM channel, the Ct value of the VIC channel is less than 40 and there is an obvious amplification curve, the Ct value of the ROX channel is less than 40 and there is an obvious amplification curve, the Ct value of the CY5 channel is less than 40 and there is an obvious amplification curve, and the Ct value of the CY5.5 channel is less than 40 and there is an obvious amplification curve, the result is determined to be African swine fever type II wild virus; When there is no Ct value in the FAM channel, the Ct of the VIC channel is less than 40 and there is an obvious amplification curve, the Ct of the ROX channel is less than 40 and there is an obvious amplification curve, the Ct of the CY5 channel is less than 40 and there is an obvious amplification curve, and there is no Ct value in the CY5.5 channel, the result is determined to be the I177L gene deletion vaccine virus; When there is no Ct value in the FAM channel, no Ct value in the VIC channel, no Ct value in the ROX channel, no Ct value in the CY5 channel, and no Ct value in the CY5.5 channel, the result is judged to be negative.

8. A method for identifying and detecting African swine fever virus, wild virus and deletion virus for non-diagnostic purposes, characterized in that: The African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deleted virus is I177L gene deleted vaccine virus; The method comprises the following steps: (1) Obtaining total DNA of the test sample; (2) preparing reagents according to the PCR amplification system described in claim 5; (3) performing PCR amplification according to the reaction conditions described in claim 6; (4) The result is determined according to the determination criteria described in claim 7.

9. Use of the primer-probe combination according to any one of claims 1 to 3 in the preparation of biological preparations for the identification and detection of African swine fever typing viruses, wild viruses and deletion viruses, characterized in that: The African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deleted virus is the I177L gene deleted vaccine virus.

10. Use of the kit according to any one of claims 4 to 7 in the preparation of an identification and detection system for African swine fever typing virus, wild virus and deletion virus, characterized in that: The African swine fever typing virus is African swine fever type I attenuated virus, African swine fever type I strong virus, African swine fever type II attenuated virus, the wild virus is African swine fever type II wild virus, and the deleted virus is the I177L gene deleted vaccine virus.

Citation Information

Cited By

  • Freeze-dried multiple fluorescent quantitative PCR (polymerase chain reaction) kit for detecting African swine fever recombinant strain

    CN120700209A